Fortis Therapeutics, Inc. logo

Fortis Therapeutics, Inc.

Fortis Therapeutics is focused on developing new antibody drug conjugate therapies for late-stage metastatic castrate-resistant prostate cancer and multiple myeloma.

Fortis Therapeutics was founded based on technology exclusively licensed from UCSF and developed in the laboratory of Dr. Bin Liu, and is a part of COI Pharmaceuticals portfolio.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Website
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
11099 North Torrey Pines Road, Suite 290,CA 92037
La Jolla
United States
Email
Contact Number
+1 858 750 4700

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

In Sep 2016, Fortis Therapeutics raised $18 Mn in Series A financing. The investment was led by Avalon Ventures and was joined by Bregua Corporation, Lilly Asia Ventures, Osage University Partners, and Vivo Capital.